Enliven Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Burlingame, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Enliven Therapeutics, Inc. has filed 784 SEC EDGAR filings since 21 Apr 2016

SEC filing history

Showing 251-275 of 784 matching filings.

Per page
25
Current page
11
144 File 001-39247

144 filing

Filing date
27 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39247

144 filing

Filing date
14 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39247

144 filing

Filing date
14 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Jan 2025
Reporting date
07 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
07 Jan 2025
Reporting date
13 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39247

144 filing

Filing date
07 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39247

144 filing

Filing date
03 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
31 Dec 2024
Reporting date
27 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39247

144 filing

Filing date
27 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39247

144 filing

Filing date
16 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39247

144 filing

Filing date
16 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Dec 2024
Reporting date
27 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39247

144 filing

Filing date
15 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39247

144 filing

Filing date
15 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91465

SC 13G/A

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91465

SC 13G/A

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91465

SC 13G/A

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91465

SC 13G/A

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91465

SC 13G/A filing

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91465

SC 13G filing

Filing date
13 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91465

SC 13G filing

Filing date
08 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
30 Oct 2024
Reporting date
28 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91465

SC 13G filing

Filing date
24 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .